These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2164580)

  • 21. Mechanism of inhibition of DNA gyrase by ES-1273, a novel DNA gyrase inhibitor.
    Oyamada Y; Yamagishi J; Kihara T; Yoshida H; Wachi M; Ito H
    Microbiol Immunol; 2007; 51(10):977-84. PubMed ID: 17951987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro inhibition of bacterial DNA gyrase by cinodine, a glycocinnamoylspermidine antibiotic.
    Osburne MS; Maiese WM; Greenstein M
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1450-2. PubMed ID: 2167040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
    Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D
    Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
    Domagala JM; Hanna LD; Heifetz CL; Hutt MP; Mich TF; Sanchez JP; Solomon M
    J Med Chem; 1986 Mar; 29(3):394-404. PubMed ID: 3005575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins.
    Fernandez-Moreira E; Balas D; Gonzalez I; de la Campa AG
    Microb Drug Resist; 2000; 6(4):259-67. PubMed ID: 11272253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy.
    Bases RE; Mendez F
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1133-7. PubMed ID: 9169823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacterial type II topoisomerases as targets for antibacterial drugs].
    Pietrusiński M; Staczek P
    Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction between coumarin drugs and DNA gyrase.
    Maxwell A
    Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structural insight into negative DNA supercoiling by DNA gyrase, a bacterial type 2A DNA topoisomerase].
    Papillon J; Ménétret JF; Batisse C; Hélye R; Schultz P; Potier N; Lamour V
    Med Sci (Paris); 2014 Dec; 30(12):1081-4. PubMed ID: 25537036
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mode of action and mechanisms of resistance of gyrase inhibitors].
    Dickgiesser N
    Immun Infekt; 1984 Nov; 12(6):298-302. PubMed ID: 6096264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of DNA topoisomerases involved in immediate and transient DNA relaxation induced by heat shock in Escherichia coli.
    Ogata Y; Mizushima T; Kataoka K; Miki T; Sekimizu K
    Mol Gen Genet; 1994 Sep; 244(5):451-5. PubMed ID: 8078472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P; Nagaraja V
    Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The twisted 'life' of DNA in the cell: bacterial topoisomerases.
    Luttinger A
    Mol Microbiol; 1995 Feb; 15(4):601-6. PubMed ID: 7783632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topoisomerase as target for antibacterial and anticancer drug discovery.
    Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmid DNA supercoiling by DNA gyrase.
    Sayer PJ; Goble ML; Oram M; Fisher LM
    Methods Mol Biol; 2001; 95():25-33. PubMed ID: 11089216
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of human topoisomerases I and II by simocyclinone D8.
    Oppegard LM; Nguyen T; Ellis KC; Hiasa H
    J Nat Prod; 2012 Aug; 75(8):1485-9. PubMed ID: 22867097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of bacterial DNA supercoiling.
    Drlica K
    Mol Microbiol; 1992 Feb; 6(4):425-33. PubMed ID: 1313943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent progress in the discovery and development of DNA gyrase B inhibitors.
    Barančoková M; Kikelj D; Ilaš J
    Future Med Chem; 2018 May; 10(10):1207-1227. PubMed ID: 29787300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The unique DNA topology and DNA topoisomerases of hyperthermophilic archaea.
    Forterre P; Bergerat A; Lopez-Garcia P
    FEMS Microbiol Rev; 1996 May; 18(2-3):237-48. PubMed ID: 8639331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA supercoiling and temperature adaptation: A clue to early diversification of life?
    López-García P
    J Mol Evol; 1999 Oct; 49(4):439-52. PubMed ID: 10486002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.